Frazier Life Sciences Public Fund, L.P. - Sep 23, 2021 Form 4 Insider Report for Viridian Therapeutics, Inc.\DE (VRDN)

Role
10%+ Owner
Signature
Frazier Life Sciences Public Fund L.P., By: FHMLSP, L.P., its General Partner. By: FHMLSP, L.L.C., its General Partner, By: /s/ Steve R. Bailey, Chief Financial Officer
Stock symbol
VRDN
Transactions as of
Sep 23, 2021
Transactions value $
$2,200,000
Form type
4
Date filed
9/28/2021, 07:46 PM
Previous filing
Aug 26, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VRDN Common Stock Purchase $2.2M +200K +15.32% $11.00 1.51M Sep 23, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Frazier Life Sciences Public Fund, L.P. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 These shares are held directly by Frazier Life Sciences Public Fund L.P. The general partner of Frazier Life Sciences Public Fund L.P. is FHMLSP, L.P. and the general partner of FHMLSP, L.P. is FHMLSP, L.L.C., and each may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Frazier Life Sciences Public Fund L.P. FHMLSP, L.P. and FHMLSP, L.L.C. each disclaim Section 16 beneficial ownership of the securities held by Frazier Life Sciences Public Fund L.P., except to the extent of its pecuniary interest therein, if any.